Latest Antibody Stories
Researchers have developed a new type of nanoparticle that can be absorbed through the digestive tract, bringing the cutting-edge treatment method one-step closer to being administered orally instead of through injections.
The immunoassay market is large and in some areas locked up by large IVD companies, but there is plenty of opportunity for innovators and for niche players developing antibody or antigen-based
A diagnostic method recently developed by UC Santa Barbara professor Patrick Daugherty can reveal — on a molecular level — the factors behind conditions thought to have environmental triggers.
Monoclonal antibodies specific to Rift Valley Fever Virus developed by Maine Biotechnology Services, in partnership with the USDA-Agricultural Research Service, are now available for sampling.
- A hairdresser.
More Images (4 images) »